The promise of digital healthcare technologies
- Creators
- Yeung, Andy Wai Kan
- Torkamani, Ali
- Butte, Atul J.
- Glicksberg, Benjamin S.
- Schuller, Björn
- Rodriguez, Blanca
- Ting, Daniel S. W.
- Bates, David
- Schaden, Eva
- Peng, Hanchuan
- Willschke, Harald
- van der Laak, Jeroen
- Car, Josip
- Rahimi, Kazem
- Celi, Leo Anthony
- Banach, Maciej
- Kletecka-Pulker, Maria
- Kimberger, Oliver
- Eils, Roland
- Islam, Sheikh Mohammed Shariful
- Wong, Stephen T.
- Wong, Tien Yin
- Gao, Wei1
- Brunak, Søren
- Atanasov, Atanas G.
Abstract
Digital health technologies have been in use for many years in a wide spectrum of healthcare scenarios. This narrative review outlines the current use and the future strategies and significance of digital health technologies in modern healthcare applications. It covers the current state of the scientific field (delineating major strengths, limitations, and applications) and envisions the future impact of relevant emerging key technologies. Furthermore, we attempt to provide recommendations for innovative approaches that would accelerate and benefit the research, translation and utilization of digital health technologies.
Copyright and License
© 2023 Yeung, Torkamani, Butte, Glicksberg, Schuller, Rodriguez, Ting, Bates, Schaden, Peng, Willschke, van der Laak, Car, Rahimi, Celi, Banach, Kletecka-Pulker, Kimberger, Eils, Islam, Wong, Wong, Gao, Brunak and Atanasov. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Funding
SB would like to thank the Novo Nordisk Foundation (grants NNF17OC0027594 and NNF14CC0001).
Contributions
AY and AA conceived, designed, and coordinated the writing of the whole manuscript. All the authors contributed to critically revise and approve the final version of this manuscript.
Conflict of Interest
Outside the submitted work SB reports ownerships in Intomics A/S, Hoba Therapeutics Aps, Novo Nordisk A/S, Lundbeck A/S, ALK abello A/S and managing board memberships in Proscion A/S and Intomics A/S.
The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Files
Name | Size | Download all |
---|---|---|
md5:d51ef87db56239f562e4a14c00986533
|
1.4 MB | Preview Download |
Additional details
- PMCID
- PMC10562722
- Novo Nordisk Foundation
- NNF17OC0027594
- Novo Nordisk Foundation
- NNF14CC0001